Genetic characterisation of Measles virus variants identified during a large epidemic in Milan, Italy, March-December 2017.

Measles (rubeola) Surveillance autochthonous and imported variants virus transmission pathways

Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 15 3 2019
pubmed: 15 3 2019
medline: 28 3 2020
Statut: ppublish

Résumé

In 2017, Italy experienced a large measles epidemic with 5408 cases and four deaths. As Subnational Reference Laboratory of the Measles and Rubella surveillance NETwork (MoRoNET), the EpiSoMI (Epidemiology and Molecular Surveillance of Infections) Laboratory (University of Milan) set up rapid and active surveillance for the complete characterisation of the Measles virus (Mv) responsible for the large measles outbreak in Milan and surrounding areas (Lombardy, Northern Italy). The aims of this study were to describe the genetic profile of circulating viruses and to track the pathway of measles transmission. Molecular analysis was performed by sequencing the highly variable 450 nucleotides region of the N gene (N-450) of Mv genome. Two-hundred and ninety-nine strains of Mv were analysed. The phylogenetic analysis showed five different variants, two not previously described in the studied area, belonging to D8 and B3 genotypes. Three events of continuous transmission of autochthonous variants (D8-Osaka, D8-London and B3-Milan variants) and two events of continuous transmission of imported variants (B3-Dublin and D8-Hulu Langat) tracked five different transmission pathways. These pathways outlined two epidemic peaks: the first in April and the second in July 2017. The correlation between Mv variant and the epidemiological data may enable us to identify the sources of virus importation and recognise long-lasting virus transmission pathways.

Identifiants

pubmed: 30869017
pii: S0950268818003606
doi: 10.1017/S0950268818003606
pmc: PMC6518568
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e80

Références

J Gen Virol. 2000 Oct;81(Pt 10):2511-8
pubmed: 10993941
Bioinformatics. 2001 Aug;17(8):754-5
pubmed: 11524383
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Mol Biol Evol. 2008 Jul;25(7):1253-6
pubmed: 18397919
J Infect Dis. 2011 Jul;204 Suppl 1:S514-23
pubmed: 21666208
Wkly Epidemiol Rec. 2012 Mar 2;87(9):73-81
pubmed: 22462199
Vaccine. 2012 Jun 8;30(27):3996-4001
pubmed: 22521843
Virol J. 2012 Nov 23;9:284
pubmed: 23173726
Vaccine. 2014 Aug 27;32(38):4814-22
pubmed: 24726251
Viruses. 2016 Apr 21;8(4):109
pubmed: 27110809
Euro Surveill. 2016 Jul 7;21(27):
pubmed: 27416791
Infect Genet Evol. 2017 Mar;48:120-126
pubmed: 27989661
Euro Surveill. 2017 Aug 17;22(33):null
pubmed: 28840826
Vaccine. 2018 Jan 11;36 Suppl 1:A1-A34
pubmed: 29307367
Can Commun Dis Rep. 2014 Jun 12;40(12):257-260
pubmed: 29769849

Auteurs

S Bianchi (S)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

E R Frati (ER)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

A Lai (A)

Department of Biomedical and Clinical Sciences 'Luigi Sacco',University of Milan,Milan,Italy.

D Colzani (D)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

G Ciceri (G)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

M Baggieri (M)

National Reference Laboratory for Measles and Rubella,Istituto Superiore di Sanità (ISS),Rome,Italy.

A Lamberti (A)

Health Protection Agency, Metropolitan Area of Milan,Milan,Italy.

S Senatore (S)

Health Protection Agency, Metropolitan Area of Milan,Milan,Italy.

M Faccini (M)

Health Protection Agency, Metropolitan Area of Milan,Milan,Italy.

F Mazzilli (F)

National Reference Laboratory for Measles and Rubella,Istituto Superiore di Sanità (ISS),Rome,Italy.

M Gramegna (M)

DG Salute, UO Governo della prevenzione e tutela sanitaria,Lombardy Region, Milan,Italy.

G Zehender (G)

Department of Biomedical and Clinical Sciences 'Luigi Sacco',University of Milan,Milan,Italy.

F Magurano (F)

National Reference Laboratory for Measles and Rubella,Istituto Superiore di Sanità (ISS),Rome,Italy.

E Tanzi (E)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

A Amendola (A)

Department of Biomedical Sciences for Health,University of Milan,Milan,Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH